Literature DB >> 19523478

Neuropeptide S: a transmitter system in the brain regulating fear and anxiety.

Hans-Christian Pape1, Kay Jüngling, Thomas Seidenbecher, Jörg Lesting, Rainer K Reinscheid.   

Abstract

The recently discovered Neuropeptide S (NPS) and its cognate receptor represent a highly interesting system of neuromodulation with unique physiological effects. On one hand, NPS increases wakefulness and arousal. On the other, NPS produces anxiolytic-like effects by acutely reducing fear responses as well as modulating long-term aspects of fear memory, such as attenuation of contextual fear or enhancement of fear extinction. The main sources of NPS in the brain are a few clusters of NPS-producing neurons in the brainstem. NPS binds to a G-protein-coupled receptor that is highly conserved among vertebrates and stimulates mobilization of intracellular Ca(2+) as well as activation of protein kinases. In synaptic circuits within the amygdala, which are important for processing of acute fear as well as formation and expression of fear memories, NPS causes increased release of the excitatory transmitter glutamate, especially in synaptic contacts to a subset of GABAergic interneurons. Polymorphisms in the human NPS receptor gene have been associated with altered sleep behavior and panic disorder. In conclusion, the NPS system displays a unique physiological profile with respect to the specificity and time course of its actions. These functions could provide interesting opportunities for both basic research and clinical applications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19523478      PMCID: PMC2784192          DOI: 10.1016/j.neuropharm.2009.06.001

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  31 in total

1.  Facilitation of conditioned fear extinction by d-cycloserine is mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase cascades and requires de novo protein synthesis in basolateral nucleus of amygdala.

Authors:  Y L Yang; K T Lu
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

2.  Dissociated theta phase synchronization in amygdalo- hippocampal circuits during various stages of fear memory.

Authors:  Rajeevan T Narayanan; Thomas Seidenbecher; Christian Kluge; Jorge Bergado; Oliver Stork; Hans-Christian Pape
Journal:  Eur J Neurosci       Date:  2007-04-04       Impact factor: 3.386

3.  Structure-function relationships in the neuropeptide S receptor: molecular consequences of the asthma-associated mutation N107I.

Authors:  Virginie Bernier; Rino Stocco; Michael J Bogusky; Joseph G Joyce; Christine Parachoniak; Karl Grenier; Michael Arget; Marie-Claude Mathieu; Gary P O'Neill; Deborah Slipetz; Michael A Crackower; Christopher M Tan; Alex G Therien
Journal:  J Biol Chem       Date:  2006-06-20       Impact factor: 5.157

Review 4.  Neural mechanisms of extinction learning and retrieval.

Authors:  Gregory J Quirk; Devin Mueller
Journal:  Neuropsychopharmacology       Date:  2007-09-19       Impact factor: 7.853

5.  Pharmacological characterization of human and murine neuropeptide s receptor variants.

Authors:  Rainer K Reinscheid; Yan-Ling Xu; Naoe Okamura; Joanne Zeng; Shinjae Chung; Rama Pai; Zhiwei Wang; Olivier Civelli
Journal:  J Pharmacol Exp Ther       Date:  2005-09-06       Impact factor: 4.030

6.  Extinction of auditory fear conditioning requires MAPK/ERK activation in the basolateral amygdala.

Authors:  Cyril Herry; Pierre Trifilieff; Jacques Micheau; Andreas Lüthi; Nicole Mons
Journal:  Eur J Neurosci       Date:  2006-07       Impact factor: 3.386

7.  Phylogenetic appearance of neuropeptide S precursor proteins in tetrapods.

Authors:  Rainer K Reinscheid
Journal:  Peptides       Date:  2007-01-20       Impact factor: 3.750

8.  Gender-specific association of a functional coding polymorphism in the Neuropeptide S receptor gene with panic disorder but not with schizophrenia or attention-deficit/hyperactivity disorder.

Authors:  Naoe Okamura; Kenji Hashimoto; Masaomi Iyo; Eiji Shimizu; Astrid Dempfle; Susann Friedel; Rainer K Reinscheid
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-07-03       Impact factor: 5.067

9.  Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders.

Authors:  Sarah K Leonard; Jason M Dwyer; Stacey J Sukoff Rizzo; Brian Platt; Sheree F Logue; Sarah J Neal; Jessica E Malberg; Chad E Beyer; Lee E Schechter; Sharon Rosenzweig-Lipson; Robert H Ring
Journal:  Psychopharmacology (Berl)       Date:  2008-03-03       Impact factor: 4.530

10.  Genome-wide association of sleep and circadian phenotypes.

Authors:  Daniel J Gottlieb; George T O'Connor; Jemma B Wilk
Journal:  BMC Med Genet       Date:  2007-09-19       Impact factor: 2.103

View more
  52 in total

Review 1.  Drug-induced sleep: theoretical and practical considerations.

Authors:  Jeffrey M Ellenbogen; Edward F Pace-Schott
Journal:  Pflugers Arch       Date:  2011-09-28       Impact factor: 3.657

Review 2.  Cortico-limbic pain mechanisms.

Authors:  Jeremy M Thompson; Volker Neugebauer
Journal:  Neurosci Lett       Date:  2018-11-29       Impact factor: 3.046

3.  Structure-activity relationship of imidazopyridinium analogues as antagonists of neuropeptide s receptor.

Authors:  Samarjit Patnaik; Juan J Marugan; Ke Liu; Wei Zheng; Noel Southall; Seameen J Dehdashti; Annika Thorsell; Markus Heilig; Lauren Bell; Michelle Zook; Bob Eskay; Kyle R Brimacombe; Christopher P Austin
Journal:  J Med Chem       Date:  2013-11-11       Impact factor: 7.446

Review 4.  Shining light on wakefulness and arousal.

Authors:  Luis de Lecea; Matthew E Carter; Antoine Adamantidis
Journal:  Biol Psychiatry       Date:  2012-03-20       Impact factor: 13.382

5.  No fear no stress with neuropeptide S.

Authors:  Helmut L Haas; Olga A Sergeeva
Journal:  J Physiol       Date:  2012-08-15       Impact factor: 5.182

6.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

7.  Central neuropeptide-S administration alleviates stress-induced impairment of gastric motor functions through orexin-A.

Authors:  Mehmet Bülbül; Osman Sinen; Onur Bayramoğlu
Journal:  Turk J Gastroenterol       Date:  2020-01       Impact factor: 1.852

8.  Genome-wide census and expression profiling of chicken neuropeptide and prohormone convertase genes.

Authors:  K R Delfino; B R Southey; J V Sweedler; S L Rodriguez-Zas
Journal:  Neuropeptides       Date:  2009-12-14       Impact factor: 3.286

9.  Neuropeptide S Activates Paraventricular Oxytocin Neurons to Induce Anxiolysis.

Authors:  Thomas Grund; Stephanie Goyon; Yuting Li; Marina Eliava; Haikun Liu; Alexandre Charlet; Valery Grinevich; Inga D Neumann
Journal:  J Neurosci       Date:  2017-11-08       Impact factor: 6.167

Review 10.  MicroRNA's impact on neurotransmitter and neuropeptide systems: small but mighty mediators of anxiety.

Authors:  Stefanie Martinetz
Journal:  Pflugers Arch       Date:  2016-04-30       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.